vimarsana.com

Latest Breaking News On - Tabuk pharmaceuticals vice - Page 1 : vimarsana.com

Saudi: Tabuk partners with Levolta to commercialise OA therapy

Under the terms of this agreement, Tabuk Pharmaceuticals will hold the marketing authorisation and will be responsible for registering, importing, and commercialising VOLT01 in the MEA region

United statesSaudi arabiaWisam alkhatibRichardp becker jrMohammed al hagbaniKetan desaiAstra industrial groupSyndigate media incTabuk pharmaceuticalsUs levolta pharmaceuticalsBusiness developmentTabuk pharmaceutical manufacturing companyMarketing groupTabuk pharmaceuticals viceLevolta pharmaceuticalsMiddle east

Levolta Pharmaceuticals Partners with Tabuk Pharmaceuticals for Commercialization of Investigational Osteoarthritis Therapy in Middle East and Africa

/PRNewswire/ Levolta Pharmaceuticals, Inc. has entered into an exclusive licensing and distribution agreement for VOLT01 with Tabuk Pharmaceutical.

Saudi arabiaWest bank generalWest bankUnited statesSouth africaRichardp becker jrMohammed al hagbaniWisam alkhatibKetan desaiTabuk pharmaceutical manufacturing company of riyadhLevolta pharmaceuticals incTabuk pharmaceuticalsAstra industrial groupLife sciencesTabuk pharmaceuticals viceCouncil for disability awareness

vimarsana © 2020. All Rights Reserved.